Drug:
Reaction: OFF LABEL USE
20260101 - 20261231
No. 401 - 500
| No. | safetyreportid |
occurcountry |
patientonsetage |
patientsex 1:M 2:F |
|---|---|---|---|---|
Adverse reaction |
||||
Drug (openfda.generic_name, medicinalproduct) |
||||
| 401 | 26560156 |
US |
25 | |
Off label use, |
||||
RUXOLITINIB, |
||||
| 402 | 26560165 |
US |
2 | |
Confusional state, Off label use, |
||||
SPARSENTAN, |
||||
| 403 | 26560174 |
US |
||
Drug ineffective, Off label use, Product physical consistency issue, |
||||
RUXOLITINIB, RUXOLITINIB, |
||||
| 404 | 26560239 |
US |
67 | 2 |
Off label use, |
||||
INSULIN GLARGINE, |
||||
| 405 | 26560253 |
US |
68 | 1 |
Off label use, |
||||
INSULIN GLARGINE, |
||||
| 406 | 26560292 |
US |
64 | 2 |
Off label use, |
||||
DUPILUMAB, |
||||
| 407 | 26560351 |
US |
2 | |
Malaise, Product dose omission issue, Off label use, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 408 | 26560359 |
US |
13 | 1 |
Off label use, |
||||
DUPILUMAB, |
||||
| 409 | 26560361 |
US |
64 | |
Off label use, |
||||
INSULIN GLARGINE, |
||||
| 410 | 26560369 |
US |
40 | 2 |
Off label use, |
||||
INSULIN GLARGINE, |
||||
| 411 | 26560385 |
US |
55 | 1 |
Off label use, |
||||
DUPILUMAB, |
||||
| 412 | 26560392 |
US |
13 | 1 |
Respiratory tract infection, Off label use, |
||||
DUPILUMAB, |
||||
| 413 | 26560412 |
US |
77 | 2 |
Off label use, |
||||
DUPILUMAB, |
||||
| 414 | 26560424 |
US |
73 | |
Off label use, |
||||
INSULIN GLARGINE, |
||||
| 415 | 26560518 |
US |
76 | 2 |
Arthritis, Back disorder, Peripheral swelling, Arthralgia, Off label use, |
||||
ABATACEPT, ABATACEPT, |
||||
| 416 | 26560534 |
US |
65 | 2 |
Drug reaction with eosinophilia and systemic symptoms, Hepatitis chronic active, Off label use, Coagulopathy, Liver injury, Toxicity to various agents, Drug ineffective, Cholestasis, Hepatic necrosis, Cytomegalovirus viraemia, |
||||
LEFLUNOMIDE, CHOLESTYRAMINE, HYDROXYCHLOROQUINE, METHYLPREDNISOLONE, CYCLOSPORINE, CYCLOSPORINE, CYCLOSPORINE, |
||||
| 417 | 26560570 |
US |
86 | 1 |
Death, Off label use, |
||||
POMALIDOMIDE, |
||||
| 418 | 26560585 |
US |
2 | |
Meningioma, Off label use, |
||||
MEDROXYPROGESTERONE ACETATE, |
||||
| 419 | 26560588 |
AU |
61 | 2 |
Death, Off label use, |
||||
ENCORAFENIB, BINIMETINIB, |
||||
| 420 | 26560600 |
CN |
6 | 1 |
Pulmonary toxicity, Off label use, |
||||
TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, BASILIXIMAB, METHYLPREDNISOLONE, |
||||
| 421 | 26560619 |
CH |
58 | 1 |
Hypotension, Headache, Dizziness, Off label use, |
||||
SPARSENTAN, |
||||
| 422 | 26560624 |
US |
40 | 2 |
Off label use, |
||||
SPARSENTAN, |
||||
| 423 | 26560645 |
CA |
38 | 1 |
Drug effective for unapproved indication, Cerebral cavernous malformation, Fatigue, Haemorrhage, Hypertension, Neutropenia, Off label use, Sinusitis, |
||||
TOCILIZUMAB, BEVACIZUMAB, |
||||
| 424 | 26560656 |
CA |
||
Hyperhidrosis, Nausea, Nephrolithiasis, Sedation, Nightmare, Drug ineffective, Product use in unapproved indication, Off label use, |
||||
PROPRANOLOL HYDROCHLORIDE, PROPRANOLOL HYDROCHLORIDE, IBUPROFEN SODIUM, IBUPROFEN, IBUPROFEN TABLETS, COATED, ALMOTRIPTAN, ALMOTRIPTAN MALATE, ONABOTULINUMTOXINA, BOTULINUM TOXIN TYPE A, CELECOXIB, MEPERIDINE HYDROCHLORIDE, DICLOFENAC, DICLOFENAC SODIUM, OXYCODONE AND ACETAMINOPHEN, ESOMEPRAZOLE, ESOMEPRAZOLE MAGNESIUM, ESOMEPRAZOLE MAGNESIUM CAPSULE, DELAYED RELEASE, ESOMEPRAZOLE MAGNESIUM DIHYDRATE, ESOMEPRAZOLE MAGNESIUM DELAYED RELEASE CAPSULES, GABAPENTIN, KETAMINE HYDROCHLORIDE, RIZATRIPTAN BENZOATE, MORPHINE SULFATE, NORTRIPTYLINE HYDROCHLORIDE, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, OXYCODONE AND ACETAMINOPHEN, OXYCODONE HYDROCHLORIDE AND ACETAMINOPHEN, OXYCODONE AND ACETAMINOPHEN TABLETS, ATENOLOL AND CHLORTHALIDONE, DULOXETINE HYDROCHLORIDE, DULOXETINE, TOPIRAMATE, TRAMADOL HYDROCHLORIDE, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, VENLAFAXINE HYDROCHLORIDE, VENLAFAXINE, |
||||
| 425 | 26560716 |
US |
45 | |
Treatment failure, Off label use, |
||||
| 426 | 26560732 |
CA |
2 | 1 |
Dermatitis, Drug ineffective for unapproved indication, Off label use, |
||||
PROPRANOLOL HYDROCHLORIDE, TRAMETINIB, TRAMETINIB, |
||||
| 427 | 26560734 |
CA |
2 | 2 |
Blood creatine phosphokinase increased, Product use in unapproved indication, Off label use, |
||||
PROPRANOLOL HYDROCHLORIDE, PROPRANOLOL HYDROCHLORIDE, PROPRANOLOL HYDROCHLORIDE, TRAMETINIB, TRAMETINIB, |
||||
| 428 | 26560735 |
CA |
4 | 1 |
Epistaxis, Rash, Drug ineffective, Product use in unapproved indication, Off label use, |
||||
PROPRANOLOL HYDROCHLORIDE, PROPRANOLOL HYDROCHLORIDE, PROPRANOLOL HYDROCHLORIDE, FUROSEMIDE, FUROSEMIDE, TRAMETINIB, TRAMETINIB, |
||||
| 429 | 26560739 |
CH |
2 | |
Off label use, |
||||
SPARSENTAN, |
||||
| 430 | 26560746 |
US |
2 | |
Organ failure, Unevaluable event, Emotional distress, Drug ineffective, Gastrointestinal injury, Liver injury, Illness, Off label use, |
||||
PANCRELIPASE, |
||||
| 431 | 26560775 |
CA |
4 | 1 |
Eczema, Oedema, Drug ineffective, Product use in unapproved indication, Off label use, |
||||
PROPRANOLOL HYDROCHLORIDE, PROPRANOLOL HYDROCHLORIDE, SPIRONOLACTONE, TRAMETINIB, |
||||
| 432 | 26560780 |
CA |
6 | 1 |
Dermatitis acneiform, Drug ineffective, Product use in unapproved indication, Off label use, |
||||
PROPRANOLOL HYDROCHLORIDE, PROPRANOLOL HYDROCHLORIDE, FUROSEMIDE, SPIRONOLACTONE, TRAMETINIB, |
||||
| 433 | 26560783 |
CA |
||
Hyperhidrosis, Nausea, Sedation, Nephrolithiasis, Nightmare, Drug ineffective, Product use in unapproved indication, Off label use, |
||||
PROPRANOLOL HYDROCHLORIDE, PROPRANOLOL HYDROCHLORIDE, ONABOTULINUMTOXINA, BOTULINUM TOXIN TYPE A, CELECOXIB, MEPERIDINE HYDROCHLORIDE, DICLOFENAC, DICLOFENAC SODIUM, OXYCODONE AND ACETAMINOPHEN, ESOMEPRAZOLE, ESOMEPRAZOLE MAGNESIUM, GABAPENTIN, HYDROMORPHONE HYDROCHLORIDE, RIZATRIPTAN BENZOATE, MORPHINE SULFATE, ONDANSETRON HYDROCHLORIDE, ATENOLOL AND CHLORTHALIDONE, DULOXETINE HYDROCHLORIDE, DULOXETINE, TOPIRAMATE, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, VENLAFAXINE HYDROCHLORIDE, VENLAFAXINE, IBUPROFEN SODIUM, IBUPROFEN, IBUPROFEN TABLETS, COATED, ALMOTRIPTAN, ALMOTRIPTAN MALATE, |
||||
| 434 | 26560795 |
US |
67 | |
Off label use, |
||||
IPILIMUMAB, NIVOLUMAB, |
||||
| 435 | 26560798 |
CA |
3 | 2 |
Drug eruption, Alopecia, Drug ineffective, Product use in unapproved indication, Off label use, |
||||
PROPRANOLOL HYDROCHLORIDE, PROPRANOLOL HYDROCHLORIDE, TRAMETINIB, |
||||
| 436 | 26560799 |
CA |
2 | 2 |
Blood creatine phosphokinase increased, Drug ineffective, Product use in unapproved indication, Off label use, |
||||
PROPRANOLOL HYDROCHLORIDE, PROPRANOLOL HYDROCHLORIDE, TRAMETINIB, |
||||
| 437 | 26560801 |
CA |
2 | 1 |
Dermatitis, Drug ineffective, Drug ineffective for unapproved indication, Off label use, |
||||
PROPRANOLOL HYDROCHLORIDE, PROPRANOLOL HYDROCHLORIDE, TRAMETINIB, TRAMETINIB, |
||||
| 438 | 26560807 |
CA |
4 | 1 |
Epistaxis, Rash, Drug ineffective, Product use in unapproved indication, Off label use, |
||||
PROPRANOLOL HYDROCHLORIDE, PROPRANOLOL HYDROCHLORIDE, FUROSEMIDE, TRAMETINIB, |
||||
| 439 | 26560830 |
EU |
2 | |
Death, Off label use, |
||||
TEPOTINIB HYDROCHLORIDE, OSIMERTINIB, OSIMERTINIB, |
||||
| 440 | 26560852 |
US |
1 | |
Off label use, |
||||
TEMOZOLOMIDE, |
||||
| 441 | 26560853 |
US |
1 | |
Off label use, |
||||
TEMOZOLOMIDE, |
||||
| 442 | 26560933 |
US |
11 | 2 |
Off label use, |
||||
SPARSENTAN, SPARSENTAN, |
||||
| 443 | 26560945 |
US |
1 | |
Disability, Off label use, |
||||
SEMAGLUTIDE, ORAL SEMAGLUTIDE, SEMAGLUTIDE, ORAL SEMAGLUTIDE, |
||||
| 444 | 26560959 |
US |
1 | |
Off label use, |
||||
SPARSENTAN, |
||||
| 445 | 26560972 |
|||
Autism spectrum disorder, Abnormal behaviour, Mood disorder due to a general medical condition, Depression, Off label use, |
||||
LEVETIRACETAM, LEVETIRACETAM IN SODIUM CHLORIDE, LEVETIRACETAM ORAL, LEVETIRACETAM INJECTION, LEVETIRACETAM, LEVETIRACETAM IN SODIUM CHLORIDE, LEVETIRACETAM ORAL, LEVETIRACETAM INJECTION, LACOSAMIDE, LACOSAMIDE, BRIVARACETAM, BRIVARACETAM INJECTION, BRIVARACETAM, BRIVARACETAM INJECTION, CARBAMAZEPINE, OXCARBAZEPINE, TOPIRAMATE, TOPIRAMATE SPINKLE, LAMOTRIGINE, LAMOTRIGINE EXTENDED-RELEASE, LAMOTRIGINE CHEWABLE DISPERSIBLE, LAMOTIRIGINE, PREGABALIN, PERAMPANEL, CANNABIDIOL, ZONISAMIDE, CENOBAMATE, RUFINAMIDE, ESCITALOPRAM, ESCITALOPRAM OXALATE, ESCITSLOPRAM, MELATONIN, LISINOPRIL, BISOPROLOL FUMARATE, MAGNESIUM, CALCIUM, |
||||
| 446 | 26560981 |
US |
1 | |
Off label use, |
||||
SPARSENTAN, SPARSENTAN, |
||||
| 447 | 26560983 |
US |
2 | |
Pulmonary embolism, Oedema peripheral, Off label use, |
||||
OSIMERTINIB, |
||||
| 448 | 26560984 |
US |
2 | |
Loss of consciousness, Vomiting, Feeling of body temperature change, Dysgeusia, Off label use, Nausea, |
||||
SEMAGLUTIDE, |
||||
| 449 | 26560986 |
58 | ||
Abdominal discomfort, Off label use, |
||||
RUXOLITINIB, TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, ACYCLOVIR, ALLOPURINOL, LORATADINE, LORATADINE TABLET, DAPSONE GEL, 5%, DAPSONE, DASPONE, FOLIC ACID, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN TABLET, FILM COATED, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, MAGNESIUM, METOPROLOL SUCCINATE, METOPROLOL SUCCINATE ER TABLETS, OLANZAPINE, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, LETERMOVIR, TACROLIMUS, ROSUVASTATIN, TRIAMCINOLONE ACETONIDE, TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05%, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, ERGOCALCIFEROL, |
||||
| 450 | 26561023 |
US |
1 | |
Off label use, |
||||
SPARSENTAN, |
||||
| 451 | 26561032 |
BR |
55 | 1 |
Appendix disorder, Pulmonary calcification, Platelet count decreased, Cholecystitis chronic, Gastrointestinal tract adenoma, Colorectal adenoma, Hepatic enzyme increased, Off label use, |
||||
CETUXIMAB, CAPECITABINE, |
||||
| 452 | 26561034 |
EU |
1 | |
Eye operation, Off label use, |
||||
CYCLOSPORINE, CYCLOSPORINE, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, |
||||
| 453 | 26561092 |
CA |
48 | 2 |
Blood pressure increased, Hot flush, Off label use, |
||||
RITUXIMAB, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, DIMENHYDRINATE, METHYLPREDNISOLONE, |
||||
| 454 | 26561111 |
EU |
17 | 2 |
Dyspnoea, Dizziness, Anxiety, Chest discomfort, Off label use, |
||||
METHOTREXATE, METHOTREXATE SODIUM, |
||||
| 455 | 26561117 |
CA |
60 | 1 |
Blood pressure diastolic abnormal, Blood pressure diastolic decreased, Blood pressure fluctuation, Blood pressure increased, Blood pressure systolic abnormal, Decreased appetite, Depression, Gastric infection, Heart rate decreased, Heart rate increased, Nausea, Oxygen saturation decreased, Weight decreased, Off label use, |
||||
RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, DIPHENHYDRAMINE HYDROCHLORIDE, CLARITHROMYCIN, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, LINEZOLID, PREGABALIN, METHYLPREDNISOLONE SODIUM SUCCINATE, METHYLPREDNISOLONE, MIRTAZAPINE, DULOXETINE HYDROCHLORIDE, DULOXETINE, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, |
||||
| 456 | 26561126 |
CA |
72 | 1 |
Productive cough, Heart rate increased, Infection, Inappropriate schedule of product administration, Off label use, |
||||
RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, DIMENHYDRINATE, DIPHENHYDRAMINE, DIPHENHYDRAMINE HYDROCHLORIDE, METHYLPREDNISOLONE, |
||||
| 457 | 26561235 |
US |
2 | |
Peripheral swelling, Off label use, |
||||
SPARSENTAN, SPARSENTAN, SPARSENTAN, |
||||
| 458 | 26561250 |
CN |
61 | 1 |
Abdominal distension, Vomiting, Generalised oedema, Discomfort, Gait inability, Off label use, |
||||
LORLATINIB, LORLATINIB, |
||||
| 459 | 26561260 |
CA |
53 | 2 |
Heart rate decreased, Hypoacusis, Meningitis, Off label use, |
||||
RITUXIMAB, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, GABAPENTIN, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN TABLET, FILM COATED, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, HUMAN IMMUNOGLOBULIN G, LEVETIRACETAM, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, METHYLPREDNISOLONE SODIUM SUCCINATE, METHYLPREDNISOLONE, LEVOTHYROXINE SODIUM, TOPIRAMATE, TOPIRAMATE SPINKLE, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, |
||||
| 460 | 26561297 |
KR |
47 | 2 |
Diaphragmatic disorder, Dyspnoea, Off label use, Abdominal pain upper, Abdominal discomfort, |
||||
TIRZEPATIDE, |
||||
| 461 | 26561317 |
US |
2 | |
Breast cancer, Off label use, |
||||
TIRZEPATIDE, |
||||
| 462 | 26561324 |
GB |
55 | 2 |
Faecal vomiting, Constipation, Abdominal pain, Weight decreased, Back pain, Cholelithiasis, Gastritis, Off label use, |
||||
TIRZEPATIDE, LANSOPRAZOLE, GLYCERIN, GLYCERIN SUPPOSITORIES, LACTULOSE, ACYCLOVIR, CLOPIDOGREL, CLOPIDOGREL BISULFATE, DOCUSATE SODIUM, DOCUSATE SODIUM 100MG, MIRTAZAPINE, ROSUVASTATIN, AMLODIPINE, INDAPAMIDE, DAPAGLIFLOZIN, |
||||
| 463 | 26561335 |
BR |
42 | 1 |
Blood glucose increased, Off label use, Inappropriate schedule of product administration, |
||||
INSULIN GLARGINE, |
||||
| 464 | 26561364 |
CA |
50 | 2 |
Pneumonia, Off label use, |
||||
GOLIMUMAB, GOLIMUMAB, |
||||
| 465 | 26561370 |
US |
28 | 1 |
Off label use, |
||||
SPARSENTAN, |
||||
| 466 | 26561382 |
US |
2 | |
Off label use, |
||||
TEMOZOLOMIDE, |
||||
| 467 | 26561385 |
US |
2 | |
Product use in unapproved indication, Off label use, |
||||
SPARSENTAN, |
||||
| 468 | 26561392 |
US |
1 | |
Off label use, |
||||
TEMOZOLOMIDE, |
||||
| 469 | 26561397 |
US |
1 | |
Off label use, |
||||
TEMOZOLOMIDE, |
||||
| 470 | 26561401 |
US |
1 | |
Off label use, |
||||
TEMOZOLOMIDE, |
||||
| 471 | 26561405 |
US |
1 | |
Off label use, |
||||
TEMOZOLOMIDE, |
||||
| 472 | 26561406 |
US |
1 | |
Off label use, |
||||
TEMOZOLOMIDE, |
||||
| 473 | 26561407 |
US |
1 | |
Off label use, |
||||
TEMOZOLOMIDE, |
||||
| 474 | 26561409 |
US |
2 | |
Off label use, |
||||
TEMOZOLOMIDE, |
||||
| 475 | 26561410 |
US |
2 | |
Off label use, |
||||
TEMOZOLOMIDE, |
||||
| 476 | 26561411 |
US |
1 | |
Off label use, |
||||
TEMOZOLOMIDE, |
||||
| 477 | 26561413 |
US |
75 | 1 |
Death, Off label use, |
||||
TEPROTUMUMAB, TEPROTUMUMAB, TEPROTUMUMAB, |
||||
| 478 | 26561414 |
US |
2 | |
Off label use, |
||||
TEMOZOLOMIDE, |
||||
| 479 | 26561415 |
US |
2 | |
Off label use, |
||||
TEMOZOLOMIDE, |
||||
| 480 | 26561422 |
US |
2 | |
Off label use, |
||||
TEMOZOLOMIDE, |
||||
| 481 | 26561424 |
US |
1 | |
Off label use, |
||||
TEMOZOLOMIDE, |
||||
| 482 | 26561430 |
US |
2 | |
Off label use, |
||||
TEMOZOLOMIDE, |
||||
| 483 | 26561437 |
US |
2 | |
Off label use, |
||||
TEMOZOLOMIDE, |
||||
| 484 | 26561440 |
US |
1 | |
Off label use, |
||||
TEMOZOLOMIDE, |
||||
| 485 | 26561442 |
US |
2 | |
Off label use, |
||||
TEMOZOLOMIDE, |
||||
| 486 | 26561443 |
US |
1 | |
Off label use, |
||||
TEMOZOLOMIDE, |
||||
| 487 | 26561485 |
US |
64 | 2 |
Off label use, Drug ineffective, Weight increased, |
||||
TIRZEPATIDE, TIRZEPATIDE, |
||||
| 488 | 26561507 |
1 | ||
Off label use, |
||||
NALTREXONE, |
||||
| 489 | 26561581 |
US |
65 | 2 |
Off label use, |
||||
NIVOLUMAB, CABOZANTINIB, |
||||
| 490 | 26561586 |
JP |
65 | 1 |
Device related infection, Peripheral artery stenosis, Off label use, Hypocalcaemia, Skin ulcer, |
||||
DARBEPOETIN ALFA, TENAPANOR HYDROCHLORIDE, LANTHANUM CARBONATE, CARVEDILOL, CARVEDILOL, CARVEDILOL, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, LINAGLIPTIN, RABEPRAZOLE SODIUM, RABEPRAZOLE, PITAVASTATIN CALCIUM, PITAVASTATIN, EZETIMIBE, FEBUXOSTAT, FEBUXOSTAT TABLETS 40 MG, FEBUXOSTAT TABLETS 80 MG, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, DROXIDOPA, DROXIDOPA, IRON SUCROSE, TIOTROPIUM BROMIDE, TIOTROPIUM BROMIDE, TIOTROPIUM BROMIDE, DEXTROMETHORPHAN HYDROBROMIDE, VANCOMYCIN HYDROCHLORIDE, VANCOMYCIN, |
||||
| 491 | 26569778 |
|||
Off label use, |
||||
DEXTROMETHORPHAN HYDROBROMIDE, BUPROPION HYDROCHLORIDE, |
||||
| 492 | 26569793 |
|||
Off label use, Dyskinesia, Overdose, |
||||
PRAMIPEXOLE, |
||||
| 493 | 26550001 |
52 | 1 | |
Pleuroparenchymal fibroelastosis, Alveolar proteinosis, Off label use, |
||||
TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, |
||||
| 494 | 26550030 |
US |
60 | 2 |
Off label use, |
||||
INSULIN GLARGINE, |
||||
| 495 | 26550031 |
US |
59 | |
Off label use, |
||||
ENOXAPARIN SODIUM, |
||||
| 496 | 26550032 |
US |
73 | 2 |
Off label use, |
||||
INSULIN GLARGINE, |
||||
| 497 | 26550039 |
US |
47 | |
Off label use, |
||||
INSULIN GLARGINE-YFGN, INSULIN GLARGINE, |
||||
| 498 | 26550050 |
CN |
48 | 1 |
Flushing, Chest discomfort, Palpitations, Off label use, Oxygen saturation decreased, |
||||
TOCILIZUMAB, TOCILIZUMAB, |
||||
| 499 | 26550059 |
US |
56 | |
Off label use, |
||||
INSULIN GLARGINE, |
||||
| 500 | 26550061 |
US |
80 | |
Off label use, |
||||
INSULIN GLARGINE AND LIXISENATIDE, |
||||
disclaimer
Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.
terms
license
last_updated
2026-04-28